Showing results (81-90 of 108) with videos related to
Sort By:
Pageof 11
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2022
Executioner caspases 3 and 7 are dispensable for intestinal epithelium turnover and homeostasis at steady stateFarzaneh Ghazavi, Jelle Huysentruyt, Jordy De Coninck, et al.Blood|September 4, 2009
Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexesJan Van den Bossche, Pieter Bogaert, Jolanda van Hengel, et al.Nucleic Acids Research|March 13, 2009
Efficient mouse transgenesis using Gateway-compatible ROSA26 locus targeting vectors and F1 hybrid ES cellsOmar Nyabi, Michael Naessens, Katharina Haigh, et al.Iscience|November 18, 2024
ZEB2 drives intra-tumor heterogeneity and skin squamous cell carcinoma formation with distinct EMP transition statesJeroen Verstappe, Nicolas Skrypek, Jordy De Coninck, et al.Nature|November 7, 2024
Colibactin-driven colon cancer requires adhesin-mediated epithelial bindingMaude Jans, Magdalena Kolata, Gillian Blancke, et al.Blood|January 11, 2017
Oncogenic ZEB2 activation drives sensitivity toward KDM1A inhibition in T-cell acute lymphoblastic leukemiaSteven Goossens, Sofie Peirs, Wouter Van Loocke, et al.Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.Molecular Oncology|May 1, 2021
The ZEB2-dependent EMT transcriptional programme drives therapy resistance by activating nucleotide excision repair genes ERCC1 and ERCC4 in colorectal cancerRahul Sreekumar, Hajir Al-Saihati, Muhammad Emaduddin, et al.Molecular Cancer Research : MCR|June 24, 2022
Distinct Transcriptional Programs in Ascitic and Solid Cancer Cells Induce Different Responses to Chemotherapy in High-Grade Serous Ovarian CancerNele Loret, Niels Vandamme, Jordy De Coninck, et al.Cell Reports|April 7, 2016
Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor ImmunityTania Løve Aaes, Agnieszka Kaczmarek, Tinneke Delvaeye, et al.Pageof 11